Which pre‑operative laboratory tests should be obtained for surgical clearance in an adult undergoing non‑cardiac surgery?

Preoperative Laboratory Testing for Surgical Clearance

For most adults undergoing non-cardiac surgery, routine preoperative laboratory testing should be selective and risk-stratified rather than universal—obtain labs only when clinically indicated based on patient age, comorbidities, surgical risk, and when results will actually change management.

Risk-Stratified Approach to Laboratory Testing

Low-Risk Surgery (endoscopic, superficial, cataract, breast procedures)

• No routine labs indicated for asymptomatic patients regardless of age 1, 2
• This includes no routine CBC, chemistry panel, coagulation studies, or ECG 3

Intermediate-Risk Surgery (intraperitoneal, intrathoracic, orthopedic, prostate)

For ASA I-II patients (healthy or mild systemic disease):

• No routine labs required if age <45 years with no cardiovascular disease 4
• Consider selective testing only if specific clinical concerns exist

For patients ≥65 years OR age 45-64 with significant cardiovascular disease:

• NT-proBNP or BNP (NT-proBNP ≥300 ng/L or BNP ≥92 ng/L indicates higher risk) 4
• Full blood count and renal function (creatinine, eGFR) 5
• ECG if ≥1 cardiac risk factor present 1, 6

For ASA III-IV patients (severe systemic disease):

• Complete blood count (hematocrit <28% or >51% increases risk) 7
• Renal function (creatinine >2 mg/dL is independent risk factor) 7
• Electrolytes if on diuretics, ACE inhibitors, or have renal disease
• Coagulation studies only if history of bleeding disorder or on anticoagulation 8

High-Risk Surgery (major vascular, intraperitoneal with large fluid shifts)

All patients require:

• Cardiac troponin (baseline, then at 24 and 48 hours postoperatively) 4, 5
• Full blood count 5
• Renal function (creatinine, eGFR) 5
• ECG 1, 6
• NT-proBNP/BNP if age ≥45 years 4

Specific Clinical Scenarios

Diabetes Mellitus

• Hemoglobin A1c to assess glycemic control
• Renal function (diabetics have higher cardiac risk) 9, 7
• Insulin-dependent diabetes is a specific cardiac risk factor requiring closer monitoring 7

Known Cardiovascular Disease

• ECG is reasonable (provides baseline for comparison) 1
• Troponin for high-risk surgery 4
• NT-proBNP/BNP for risk stratification 4
• Renal function (often coexists with cardiac disease) 7

Renal Impairment

• Creatinine >177 μmol/L (>2 mg/dL) is a major cardiac risk factor 4, 7
• Calculate creatinine clearance or eGFR (more accurate than creatinine alone) 7
• Recheck if on ACE inhibitors or diuretics

Anemia or Bleeding Risk

• CBC if history suggests anemia or polycythemia 7
• Hematocrit <28% increases perioperative ischemia risk 7
• Coagulation studies (PT/PTT) only if:
  • History of bleeding disorder
  • On anticoagulation therapy
  • Liver disease suspected
  • NOT routine 8

What NOT to Order

Class III (Not Recommended):

• Routine ECG in asymptomatic patients undergoing low-risk surgery 1, 6
• Routine chest X-ray (obtain only if respiratory symptoms or specific indication) 8
• Routine coagulation studies without bleeding history 8
• Routine liver function tests without liver disease history
• Any test that won't change management 2, 3

Critical Pitfalls to Avoid

1. The "panel ordering" trap: Studies show 41.9% of tests in ASA-I patients and 17.7% in ASA-II patients are unnecessary, wasting resources and risking false positives 10

2. False reassurance: Abnormal results are common (42-51% of ECGs and chest X-rays show abnormalities) but rarely change management 11

3. Timing matters: Order tests close enough to surgery that results are current, but early enough to act on abnormalities

4. The "baseline" myth: Obtaining tests "for baseline comparison" is not justified unless clinically indicated 1, 3

Evidence Quality Note

The 2024 AHA/ACC guideline 2 and 2017 Canadian guidelines 4 represent the most current evidence, superseding older ACC/AHA recommendations 9, 1. The European guidelines 5, 12 align with North American recommendations on selective rather than routine testing. High-quality randomized trials consistently show no benefit to routine preoperative testing in healthy patients undergoing low-risk surgery 3.

The key principle: Order tests only when results will influence perioperative management decisions—not reflexively based on age or surgery type alone.